Murine aldo-keto reductase family 1 subfamily B: Identification of AKR1B8 as an ortholog of human AKR1B10

Biological Chemistry

Volumn 391, Issue 12, 2010, Pages 1371-1378

  Joshi, Amit ^a   Rajput, Sandeep ^a   Wang, Chun ^a   Ma, Jun ^a   Cao, Deliang ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetyl CoA carboxylase ; AKR1B8 knockdown; Aldo keto reductase family 1 member B10 (AKR1B10); Aldo keto reductase family 1 member B8 (AKR1B8); Mouse ortholog

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALDO KETO REDUCTASE FAMILY 1 MEMBER B10; ALDO KETO REDUCTASE FAMILY 1 MEMBER B3; ALDO KETO REDUCTASE FAMILY 1 MEMBER B7; ALDO KETO REDUCTASE FAMILY 1 MEMBER B8; OXIDOREDUCTASE; UNCLASSIFIED DRUG; AKR1B10 PROTEIN, HUMAN; AKRB7 PROTEIN, MOUSE; ALDEHYDE REDUCTASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; COLON CANCER; COMPUTER MODEL; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; MOUSE; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; TISSUE DISTRIBUTION; ANIMAL; C57BL MOUSE; CELL STRAIN 3T3; GENETICS; HUMAN; METABOLISM; NEOPLASM;

MURINAE; MUS;

ACETYL-COA CARBOXYLASE; ALDEHYDE REDUCTASE; ANIMALS; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASMS; NIH 3T3 CELLS;

EID: 79952523150     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.144     Document Type: Article

References (36)

1. Barski, O.A., Tipparaju, S.M., and Bhatnagar, A. (2008). The aldoketo reductase superfamily and its role in drug metabolism and detoxification. Drug Metab. Rev. 40, 553-624.
2. Bohren, K.M., Bullock, B., Wermuth, B., and Gabbay, K.H. (1989). The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J. Biol. Chem. 264, 9547-9551.
3. Cao, D., Fan, S.T., and Chung, S.S. (1998). Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273, 11429-11435. (Pubitemid 28272034)
4. Chung, S. and LaMendola, J. (1989). Cloning and sequence determination of human placental aldose reductase gene. J. Biol. Chem. 264, 14775-14777. (Pubitemid 19237295)
5. Crosas, B., Hyndman, D.J., Gallego, O., Martras, S., Pares, X., Flynn, T.G., and Farres, J. (2003). Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem. J. 373, 973-979. (Pubitemid 36981109)
6. Donohue, P.J., Alberts, G.F., Hampton, B.S., and Winkles, J.A. (1994). A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J. Biol. Chem. 269, 8604-8609. (Pubitemid 24200289)
7. Fukumoto, S., Yamauchi, N., Moriguchi, H., Hippo, Y., Watanabe, A., Shibahara, J., Taniguchi, H., Ishikawa, S., Ito, H., Yamamoto, S., et al. (2005). Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' nonsmall cell lung carcinomas. Clin. Cancer Res. 11, 1776-1785. (Pubitemid 40471839)
8. Gallego, O., Ruiz, F.X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A.R., Rovira, C., Farres, J., Fita, I., and Pares, X. (2007). Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. Proc. Natl. Acad. Sci. USA 104, 20764-20769.
9. Guex, N. and Peitsch, M.C. (1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723. (Pubitemid 28059943)
10. Gui, T., Tanimoto, T., Kokai, Y., and Nishimura, C. (1995). Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse. Eur. J. Biochem. 227, 448-453.
11. Jez, J.M., Flynn, T.G., and Penning, T.M. (1997). A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54, 639-647. (Pubitemid 27404623)
12. Jin, Y. and Penning, T.M. (2007). Aldo-keto reductases and bioactivation/detoxication. Annu. Rev. Pharmacol. Toxicol. 47, 263-292.
13. Jin, J., Krishack, P.A., and Cao, D. (2006). Role of aldo-keto reductases in development of prostate and breast cancer. Front. Biosci. 11, 2767-2773. (Pubitemid 43806578)
14. Klysik, J. (2002). Mice and humans: chromosome engineering and its application to functional genomics. Acta Biochim. Pol. 49, 553-569. (Pubitemid 135700583)
15. Lau, E.T., Cao, D., Lin, C., Chung, S.K., and Chung, S.S. (1995). Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem. J. 312, 609-615. (Pubitemid 26002232)
16. Lee, K.W., Ko, B.C., Jiang, Z., Cao, D., and Chung, S.S. (2001). Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 12, 129-132. (Pubitemid 32207361)
17. Lefrancois-Martinez, A.M., Tournaire, C., Martinez, A., Berger, M., Daoudal, S., Tritsch, D., Veyssiere, G., and Jean, C. (1999). Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells. J. Biol. Chem. 274, 32875-32880. (Pubitemid 129535323)
18. Licht, T., Herrmann, F., Gottesman, M.M., and Pastan, I. (1997). In vivo drug-selectable genes: a new concept in gene therapy. Stem Cells 15, 104-111. (Pubitemid 27152517)
19. Ma, J., Yan, R., Zu, X., Cheng, J.M., Rao, K., Liao, D.F., and Cao, D. (2008). Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-α in breast cancer cells. J. Biol. Chem. 283, 3418-3423.
20. Martin, H.J., Breyer-Pfaff, U., Wsol, V., Venz, S., Block, S., and Maser, E. (2006). Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab. Dispos. 34, 464-470. (Pubitemid 43290905)
21. Martinez, A., Pailhoux, E., Berger, M., and Jean, C. (1990). Androgen regulation of the mRNA encoding a major protein of the mouse vas deferens. Mol. Cell. Endocrinol. 72, 201-211. (Pubitemid 20282132)
22. Marti-Renom, M.A., Stuart, A.C., Fiser, A., Sanchez, R., Melo, F., and Sali, A. (2000). Comparative protein structure modeling of genes and genomes. Annu. Rev. Biophys. Biomol. Struct. 29, 291-325. (Pubitemid 30599596)
23. Mindnich, R.D. and Penning, T.M. (2009). Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum. Genomics 3, 362-370.
24. Penning, T.M. and Drury, J.E. (2007). Human aldo-keto reductases: function, gene regulation, and single nucleotide polymorphisms. Arch. Biochem. Biophys. 464, 241-250. (Pubitemid 47214569)
25. Petrash, J.M. (2004). All in the family: aldose reductase and closely related aldo-keto reductases. Cell. Mol. Life Sci. 61, 737-749. (Pubitemid 38659658)
26. Petrash, J.M., Harter, T.M., Srivastava, S., Chandra, A., Bhatnagar, A., and Srivastava, S.K. (1999). Structure-function studies of FR-1. A growth factor-inducible aldo-keto reductase. Adv. Exp. Med. Biol. 463, 435-443.
27. Quinn, A.M., Harvey, R.G., and Penning, T.M. (2008). Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10. Chem. Res. Toxicol. 21, 2207-2215.
28. Scuric, Z., Stain, S.C., Anderson, W.F., and Hwang, J.J. (1998). New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma. Hepatology 27, 943-950. (Pubitemid 28160478)
29. Srivastava, S., Harter, T.M., Chandra, A., Bhatnagar, A., Srivastava, S.K., and Petrash, J.M. (1998). Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry 37, 12909-12917. (Pubitemid 28433524)
30. Tramontano, A., Leplae, R., and Morea, V. (2001). Analysis and assessment of comparative modeling predictions in CASP4. Proteins Suppl. 5, 22-38. (Pubitemid 34113165)
31. Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D.F., and Cao, D. (2009). Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J. Biol. Chem. 284, 26742-26748.
32. Yan, R., Zu, X., Ma, J., Liu, Z., Adeyanju, M., and Cao, D. (2007). Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: implication for cancer intervention. Int. J. Cancer. 121, 2301-2306. (Pubitemid 47585613)
33. Yasuda, N., Fujino, K., Shiraji, T., Nambu, F., and Kondo, K. (1997). Effects of steroid 5a-reductase inhibitor ONO-9302 and antiandrogen allylestrenol on the prostatic growth, and plasma and prostatic hormone levels in rats. Jpn. J. Pharmacol. 74, 243-252. (Pubitemid 27376038)
34. Yoshitake, H., Takahashi, M., Ishikawa, H., Nojima, M., Iwanari, H., Watanabe, A., Aburatani, H., Yoshida, K., Ishi, K., Takamori, K., et al. (2007). Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer. 17, 1300-1306. (Pubitemid 350077355)
35. Zhong, L., Liu, Z., Yan, R., Johnson, S., Zhao, Y., Fang, X., and Cao, D. (2009). Aldo-keto reductase family 1 B10 protein detoxifies dietary and lipid-derived a,b-unsaturated carbonyls at physiological levels. Biochem. Biophys. Res. Commun. 387, 245-250.
36. Zu, X., Yan, R., Robbins, S., Krishack, P.A., Liao, D.F., and Cao, D. (2007). Reduced 293T cell susceptibility to acrolein due to aldose reductase-like-1 protein expression. Toxicol. Sci. 97, 562-568. (Pubitemid 47073870)